A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.

Phase 4

Innovative Medical